Dysregulated NLRP3 inflammasome activity contributes to the pathogenesis of diverse inflammatory conditions, including autoimmune disorders, cancer, respiratory diseases, cardiovascular dysfunction, neurodegeneration, and metabolic syndromes [1,13,31,32]. The gene discussed is NLRP3; the disease is metabolic syndrome.